Mark Zimmerman MD
Professor, Psychiatry and Human Behavior, Brown University Program in Medicine
Join to View Full Profile
1170 Pontiac AveCranston, RI 02920
Phone+1 401-500-0424
Fax+1 855-268-5333
Dr. Zimmerman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Drexel University College of Medicine/Hahnemann University HospitalResidency, Psychiatry, 1990 - 1994
Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 1990
Certifications & Licensure
MA State Medical License 2025 - 2026
RI State Medical License 1994 - 2026
VT State Medical License 2025 - 2026
PA State Medical License 1992 - 1994
American Board of Psychiatry and Neurology Psychiatry
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Cloverleaf Integration Suite, Infor (US), Inc., 2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2017
Clinical Trials
- Safety, Tolerability and Activity of SRX246 in Adults With Intermittent Explosive Disorder Start of enrollment: 2014 May 01
Publications & Presentations
PubMed
- How Many Criteria Should Be Required to Define the DSM-5 Mixed Features Specifier in Depressed Patients?Mark Zimmerman, Daniel Mackin
The Journal of Clinical Psychiatry. 2026-01-21 - Revisiting the structure of Diagnostic and Statistical Manual of Mental Disorders, fifth edition, Section II personality disorder criteria using individual participant...Steffen Müller, Ulrich Schroeders, Nathan Bachrach, Cord Benecke, Lara Cuevas
Personality Disorders. 2026-01-01 - The contributions of social functioning and emotion dysregulation to depression severity in patients with depressive disorders.Matthew D Snyder, Mark Zimmerman
Journal of Affective Disorders. 2026-01-01
Journal Articles
- Validity of the DSM‐5 Anxious Distress Specifier for Major Depressive DisorderKristy Dalrymple, Mark Zimmerman, Depression and Anxiety
Other
- Using scales to monitor symptoms and treatment of depression (measurement based care)Zimmerman M
http://www.uptodate.com/contents/using-scales-to-monitor-symptoms-and-treatment-of-depression-measur
UpToDate, Wolters Kluwer Health - 2013-04-09
Press Mentions
Can Relmada’s Fast-Acting Pill for Major Depressive Disorder Compete in a Crowded Market?May 5th, 2022- Telehealth Safe, Effective for a Challenging Psychiatric DisorderNovember 11th, 2021
- Patient Satisfaction High for Psychiatric Telehealth Platforms in Partial Hospital ProgramMarch 25th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
